Moderna Files FDA Application For The Lp.8.1 Targeting Covid-19 Vaccine
RefinitivMenos de 1 minuto de lectura
Moderna Inc 
MRNA:
MODERNA FILES FDA APPLICATION FOR THE LP.8.1 TARGETING COVID-19 VACCINE
MODERNA: SUBMISSION BASED ON GUIDANCE FROM U.S. FDA, WHICH ADVISED THAT COVID-19 VACCINES SHOULD BE UPDATED TO A MONOVALENT JN.1 LINEAGE - WEBSITE
Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia